BBIO
BridgeBio Pharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
BBIO fundamentals
BridgeBio Pharma (BBIO) released its earnings on Oct 29, 2025: revenue was 120.70M (YoY +4318.01%), beat estimates; EPS was -0.95 (YoY -10.47%), missed estimates.
Revenue / YoY
120.70M
+4318.01%
EPS / YoY
-0.95
-10.47%
Report date
Oct 29, 2025
BBIO Earnings Call Summary for Q3,2025
- Phase III Triumphs: BBP-418 (80% glycosylation improvement) and encaleret (76% calcium normalization) exceed expectations, solidifying first-in-class status.
- Attruby Dominance: $108.1M Q3 sales, targeting 30%+ market share with unique efficacy (43% CVH risk reduction) and lowest price point.
- Pipeline Expansion: Infigratinib Phase III readout in early 2026; chronic hypoparathyroidism and achondroplasia each project $2B+ opportunities.
- Financial Strength: $645.9M cash runway supporting commercial growth and late-stage trials.
EPS
Revenue
Revenue & Expenses
BBIO has released its 2025 Q3 earnings report, with revenue of 120.70M, reflecting a YoY change of 4318.01%, and net profit of -184.94M, showing a YoY change of -12.59%. The Sankey diagram below clearly presents BBIO's revenue sources and cost distribution.
Key Indicators
BridgeBio Pharma (BBIO) key financial stats and ratios, covering profitability, financial health, and leverage.
BridgeBio Pharma (BBIO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
BridgeBio Pharma (BBIO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
BridgeBio Pharma (BBIO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does BridgeBio Pharma (BBIO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track BridgeBio Pharma (BBIO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from BridgeBio Pharma's earnings call?What is the market's earnings forecast for BridgeBio Pharma next quarter?What guidance did BridgeBio Pharma's management provide for the next earnings period?Did BridgeBio Pharma beat or miss consensus estimates last quarter?What were the key takeaways from BridgeBio Pharma’s earnings call?What is BridgeBio Pharma's gross profit margin?What does BridgeBio Pharma do and what are its main business segments?What is BridgeBio Pharma's latest dividend and current dividend yield?
